 | Up a level |
2022
Ceccon, G. S., Werner, J., Ruge, M., I, Goldbrunner, R., Celik, E., Baues, C., Deckert, M., Brunn, A., Buttner, R., Golla, H., Nogova, L., Schlamann, M., Kabbasch, C., Ruess, D., Hampl, J., Wollring, M., Bauer, E. K., Tscherpel, C., Fink, G. R., Langen, K. and Galldiks, N. (2022). Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Fuertjes, G., Weitzenberg, M., Arus, B., Rolbieski, H., Mawrin, C., Goldbrunner, R., Plettenburg, O., Bruns, O. and Neuschmelting, V (2022). Development of a somatostatin receptor type 2 (SSTR2)-targeted probe for near infrared fluorescence guided meningioma surgery. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Juenger, S. T., Meissner, A., Ruge, M., I, Ruess, D., Goldbrunner, R. and Grau, S. (2022). THE CLINICAL COURSE OF LONG-TERM SURVIVORS AFTER THE DIAGNOSIS OF BRAIN METASTASIS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kocher, M., Jockwitz, C., Lohmann, P., Stoffels, G., Filss, C., Motthagy, F. M., Ruge, M., I, Weiss Lucas, C., Goldbrunner, R., Shah, N. J., Fink, G. R., Galldiks, N., Langen, K. and Caspers, S. (2022). LESION-FUNCTION ANALYSIS FROM MULTIMODAL IMAGING AND NORMATIVE BRAIN ATLASES FOR PREDICTION OF COGNITIVE DEFICITS IN GLIOMA PATIENTS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Meissner, A., Gutsche, R., Galldiks, N., Kocher, M., Junger, S., Eich, M., Nogova, L., Schmidt, N., Ruge, M., Goldbrunner, R., Proescholdt, M., Grau, S. and Lohmann, P. (2022). RADIOMICS FOR THE NON-INVASIVE ASSESSMENT OF THE PDL-1 EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Werner, J., Wolf, L., Tscherpel, C., Bauer, E. K., Wollring, M., Ceccon, G., Deckert, M., Brunn, A., Pappesch, R., Goldbrunner, R., Fink, G. R. and Galldiks, N. (2022). EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Wollring, M. M., Werner, J., Bauer, E. K., Tscherpel, C., Lohmann, P., Kabbasch, C., Goldbrunner, R., Fink, G. R., Langen, K. J. and Galldiks, N. (2022). PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RELAPSE USING MRI AND FET PET. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2021
Grau, S., Herling, M., Mauch, C., Galldiks, N., Golla, H., Schlamann, M., Scheel, A. H., Celik, E., Ruge, M. and Goldbrunner, R. (2021). Brain metastases-Interdisciplinary approach towards a personalized treatment. Chirurg, 92 (3). S. 200 - 210. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0385
2020
Baehr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R. and Glas, M. (2020). The use of TTFields in Germany in routine clinical care of newly diagnosed GBM patients (TIGER: TTFields in Germany in routine clinical care). Strahlenther. Onkol., 196 (SUPPL 1). S. S63 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
2018
Baehr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R. and Glas, M. (2018). THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE). Neuro-Oncology, 20. S. 252 - 253. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Dinh, D. T. D., Kuhl, S., Roehn, G., Goldbrunner, R. and Timmer, M. (2018). CHMP4B IS UPREGULATED IN MENINGIOMAS. Neuro-Oncology, 20. S. 275 - 277. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Dinh, D. T. D., Kuhl, S., Roehn, G., Goldbrunner, R. and Timmer, M. (2018). ENO1 IST DOWNREGULATED IN MENINGIOMAS AND UPREGULATED IN LOW GRADE GLIOMAS. Neuro-Oncology, 20. S. 294 - 295. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Goertz, L., Hamisch, C., Erdner, N., Muders, H., Goldbrunner, R., von Spreckelsen, N., Stavrinou, P., Krischek, B. and Timmer, M. (2018). INDEPENDENT RISK FACTORS FOR PRE- AND POSTOPERATIVE SEIZURES IN MENINGIOMA PATIENTS IDENTIFIED BY LOGISTIC REGRESSION ANALYSIS. Neuro-Oncology, 20. S. 319 - 320. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Grau, S., Denizci, C., von Spreckelsen, N., Goldbrunner, R., Boettiger, B. W. and Hinkelbein, J. (2018). The choice of the hypnotic drug (volatile or propofol) for maintenance of anesthesia does not influence surgical conditions during cranioplasty. J. Anaesth. Clin. Pharm., 34 (2). S. 172 - 177. MUMBAI: WOLTERS KLUWER MEDKNOW PUBLICATIONS. ISSN 2231-2730
Kuhl, S., Roehn, G., Goldbrunner, R. and Timmer, M. (2018). THE EXPRESSION OF CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4) IS UPREGULATED IN HIGH GRADE GLIOMAS. Neuro-Oncology, 20. S. 297 - 299. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Papazacharias, E., Roehn, G., Goldbrunner, R. and Timmer, M. (2018). RELATION OF THE EXPRESSION BETWEEN TERT AND GABPA/B ISOFORMS IN GLIOMAS USING QUANTITATIVE REAL TIME-PCR. Neuro-Oncology, 20. S. 295 - 296. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Stegmann, S., Werner, J., Kuhl, S., Roehn, G., Goldbrunner, R. and Timmer, M. (2018). DEATH RECEPTOR 6 (DR6) IS OVEREXPRESSED IN ASTROCYTOMAS. Neuro-Oncology, 20. S. 298 - 299. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Timmer, M., Kauke, M., Safi, A., Krischek, B. and Goldbrunner, R. (2018). SEMIAUTOMATIC IMAGE SEGMENTATION BASED VOLUME APPROXIMATION OF INTRACRANIAL MENINGIOMAS. Neuro-Oncology, 20. S. 321 - 322. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Werner, J., Kuhl, S., Krischek, B., Goldbrunner, R. and Timmer, M. (2018). THE EXPRESSION OF CD40 CORRELATES NEGATIVELY WITH OVERALL SURVIVAL OF GLIOMAS. Neuro-Oncology, 20. S. 260 - 261. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2017
Kebir, S., Schaefer, N., Hattingen, E., Steinbach, J., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Herrlinger, U. and Glas, M. (2017). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 74 - 75. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kebir, S., Stummer, W., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Vatter, H., Herrlinger, U. and Glas, M. (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA. RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 112 - 113. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Stavrinou, P., Kalyvas, A., Katsigiannis, S., Hamisch, C., Krischek, B., Stranjalis, G. and Goldbrunner, R. (2017). COMPARISON OF THE EFFECT OF DIFFERENT TREATMENT STRATEGIES WITHIN DISCREPANT HEALTH-CARE SYSTEMS ON SURVIVAL OF GLIOBLASTOMA PATIENTS. Neuro-Oncology, 19. S. 82 - 84. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Tutunji, J., Grau, S. J., Ruess, D., Kocher, M., Treuer, H., Goldbrunner, R. and Ruge, M. I. (2017). STEREOTACTIC RADIOSURGERY FOR THE TREATMENT OF MENINGIOMAS ELIGIBLE FOR COMPLETE RESECTION. Neuro-Oncology, 19. S. 16 - 18. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Werner, J., Roehn, G., Goldbrunner, R. and Timmer, M. (2017). ENPP3 OVEREXPRESSION IN ASTROCYTOMAS. Neuro-Oncology, 19. S. 51 - 52. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2016
Hamisch, C. A., Kellermann, S., Blau, T., Grau, S., Goldbrunner, R. and Ruge, M. I. (2016). OVERALL SURVIVAL OF PRIMARY HIGH-GRADE GLIOMAS OF SUPRA- AND INFRATENTORIAL MIDLINE STRUCTURES. Neuro-Oncology, 18. S. 48 - 50. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Neuschmelting, V., Lucas, C. Weiss, Stoffels, G., Oros-Peusquens, A. -M., Lockau, H., Shah, N. J., Langen, K. -J., Goldbrunner, R. and Grefkes, C. (2016). Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach. Am. J. Neuroradiol., 37 (2). S. 266 - 274. DENVILLE: AMER SOC NEURORADIOLOGY. ISSN 1936-959X
Stavrinou, P., Hartl, R., Krischek, B., Kabbasch, C., Mpotsaris, A. and Goldbrunner, R. (2016). Navigated Transtubular Extraforaminal Decompression of the L5 Nerve Root at the Lumbosacral Junction: Clinical Data, Radiographic Features, and Outcome Analysis. Biomed Res. Int., 2016. LONDON: HINDAWI LTD. ISSN 2314-6141
Telentschak, S., Rohn, G., Grau, S., Krischek, B., Goldbrunner, R. and Timmer, M. (2016). THE RAN SIGNALING PATHWAY IS UPREGULATED DEPENDENT FROM GLIOMA GRADE AND RADIOCHEMOTHERAPY. Neuro-Oncology, 18. S. 57 - 58. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Timmer, M., Kannampuzha, S., Rohn, G. and Goldbrunner, R. (2016). INHIBITION OF MUTT HOMOLOG 1 (MTH1) IN GLIOBLASTOMA MULTIFORME RESULTS IN IMPAIRED CELL MIGRATION AND TUMOR GROWTH. Neuro-Oncology, 18. S. 57 - 58. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Van Dyck, E., Erasimus, H., Gobin, M., Nazarov, P., Fritah, S., Vallar, L., Timmer, M., Goldbrunner, R. and Niclou, S. (2016). TARGETING DNA REPAIR MECHANISMS IN GLIOBLASTOMA: FROM BASIC MECHANISMS TO PRE-CLINICAL ASPECTS AND PERSONALIZED THERAPY. Neuro-Oncology, 18. S. 19 - 21. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2015
Heimann, S. M., Vehreschild, J. J., Cornely, O. A., Wisplinghoff, H., Hallek, M., Goldbrunner, R., Boettiger, B. W., Goeser, T., Hoelscher, A., Baldus, S., Mueller, F., Jazmati, N., Wingen, S., Franke, B. and Vehreschild, M. J. G. T. (2015). Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital. Infection, 43 (6). S. 707 - 715. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973
2014
Dreher, L., Perrech, M., Roehn, G., Goldbrunner, R., Saric, T. and Timmer, M. (2014). Evaluation of stem cell markers and different stemness genes in glioblastoma cell lines. Oncol. Res. Treat., 37. S. 119 - 120. BASEL: KARGER. ISSN 2296-5262
Dreher, L., Perrech, M., Roehn, G., Goldbrunner, R. and Timmer, M. (2014). Allele-specific real-time RT-PCR for the detection of IDH1 mutations in gliomas: Mutant and wildtype IDH1 are upregulated in human gliomas whereas systemic treatment and tumor relapse do not change IDH1 gene expression. Oncol. Res. Treat., 37. S. 25 - 26. BASEL: KARGER. ISSN 2296-5262
Dreher, L., Roehn, G., Perrech, M., Goldbrunner, R. and Timmer, M. (2014). EXPRESSION OF PLURIPOTENCY STEMNESS GENES IN HUMAN GLIOMAS OF DIFFERENT TUMOR GRADES BEFORE AND AFTER CHEMOTHERAPY. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Kebir, S., Goldbrunner, R., Ruge, M. I., Schmidt, M. and Langen, K. (2014). DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Herrlinger, U., Schaefer, N., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W. and Glas, M. (2014). THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J. and Ruge, M. I. (2014). LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Timmer, M., Cramer, C., Roehn, G. and Goldbrunner, R. (2014). Changes in the Progesterone-, Estrogen-, HER2/neureceptor status and the proliferation marker Ki-67 in metastasized breast cancer: Discordance rates and time to progression in brain metastasis. Oncol. Res. Treat., 37. S. 67 - 68. BASEL: KARGER. ISSN 2296-5262
Timmer, M., Perrech, M., Roehn, G., Ruess, D., Blau, T., Breuer, N., Goldbrunner, R. and Ruge, M. (2014). MOLECULAR ANALYSIS OF STEREOTACTIC BIOPSIES COMPARED TO TISSUE SAMPLES FROM OPEN TUMOR RESECTIONS IN GLIOMAS. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Timmer, M., Seibl-Leven, M., Wittenstein, K. and Goldbrunner, R. (2014). LONG TERM QUALITY OF LIFE OF ELDERLY PEOPLE IN DIFFERENT AGE GROUPS AFTER MENINGIOMA SURGERY. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Timmer, M., Tjiong, R., Roehn, G. and Goldbrunner, R. (2014). Expression of human aryl hydrocarbon receptor and ARNT is upregulated after chemotherapy in recurrent glioblastoma multiforme. Oncol. Res. Treat., 37. S. 128 - 129. BASEL: KARGER. ISSN 2296-5262
Werner, J., Roehn, G., Breuer, N., Goldbrunner, R. and Timmer, M. (2014). DIFFERENCES IN THE EXPRESSION OF CD184, CD95, CD178 AND CD40 IN HUMAN GLIOMAS OF VARIOUS GRADES, BEFORE AND AFTER CHEMOTHERAPY. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2012
Sanchez, R., Karow, M., Schichor, C., Masserdotti, G., Ortega, F., Heinrich, C., Gascon, S., Khan, M. A., Lie, D. C., Dellavalle, A., Cossu, G., Goldbrunner, R., Goetz, M. and Berninger, B. (2012). Direct conversion of pericyte-derived cells of the adult human brain into functional neurons. Int. J. Dev. Neurosci., 30 (8). S. 631 - 632. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0736-5748